would call for development of comprehensive protocols for medicinal plant production to ensure quality
and reproducibility in the raw material utilized in the production of botanical medicines. A major objec-
tive of these guidelines is harmonizing phytopharmaceutical quality requirements within the European
Union countries [82].
The use of molecular and biotechnology approaches to medicinal plants would also have wide ap-
plication and promise, especially with regard to such topics as the modification of phytomedicinal chem-
ical pathways [6,83], growth and propagation of medicinal plants in vitro, and the in vitro production of
phytomedicinals in large-scale tissue culture systems such as bioreactors [84].
REFERENCES
- B Griggs. Green Pharmacy. The History and Evolution of Western Herbal Medicine. Rochester, VT: Healing
Arts Press, 1997. - WHO. Guidelines for the Appropriate Use of Herbal Medicines. Manila: World Health Organization, 1998.
- VE Tyler. Phytomedicines: back to the future. J Nat Prod 62:1589–1592, 1999.
- P Brevoort P. The blooming U.S. botanical market. A new overview. Herbalgram 44:33–46, 1998.
- V Glaser. Billion-dollar market blossoms as botanicals take root. Nat Biotechnol 17:17–18, 1999.
- RA Dixon. Plant natural products: the molecular genetic basis of biosynthetic diversity. Curr Opin Biotechnol
10:192–197, 1999. - M Wink. Introduction: biochemistry, role and biotechnology of secondary products. In: M Wink, ed. Biochem-
istry of Secondary Product Metabolism. Boca Raton, FL: CRC Press, 1999, pp 1–16. - PB Kaufman, LJ Cseke, S Warber, JA Duke, HL Brielmann. Natural Products from Plants. Boca Raton, FL:
CRC Press, 1999. - M Wink, O Schimmer. Modes of action of defensive secondary metabolites. In: M Wink, ed. Functions of Plant
Secondary Metabolites and Their Exploitation in Biotechnology. Boca Raton, FL: CRC Press, 1999, pp 17–112. - M Blumenthal. Herb market levels after five years of boom: 1999 sales in mainstream market up only 11% in
first half of 1999 after 55% increase in 1998. Herbalgram 47:64–65, 1999. - H Huh, EJ Staba. The botany and chemistry of Ginkgo bilobaL. J Herb Spices Med Plant 1:91–124, 1992.
- J Bruneton. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris: Lavisior, 1995.
- KC Huang. Pharmacology of Chinese Herbs. Boca Raton, FL: CRC Press, 1999.
- J Kleijinen, P Knipschild. Ginkgo biloga. Lancet 340:1136–1139, 1992.
- V Schultz, R Hänsel, V Tyler. Rational Phytotherapy. A Physician’s Guide to Herbal Medicine, Berlin:
Springer-Verlag, 1998. - B Ahlemeyer, J Krieglstein. Neuroprotective effects of Ginkgo bilobaextract. In: LD Lawson, R Bauer, eds.
Phytomedicines of Europe. Chemistry and Biological Activity. Washington, DC: American Chemical Society,
1998, pp 210–220. - J Kleijinen, P Knipschild. Ginkgo bilobafor cerebral insufficiency. Br J Clin Pharmacol 34:352–358, 1992.
- M Blumenthal, A Goldberg, A Binckmann. Herbal Medicine. Expanded Commission E Monographs. Boston:
Integrative Medicine Communications, 2000. - PM Dewick. Medicinal Natural Products. West Sussex, UK: John Wiley & Sons, 1997.
- O Sticher. Quality of Gingkopreparations. Planta Med 59:2–11, 1993.
- World Health Organization. WHO Monographs on Selected Medicinal Plants, Vol 1. Geneva: WHO, 1999.
- A Cartayrade, E Neau, C Sohier, JP Balz, JP Carde, J Walter. Ginkgolide and bilobalide biosynthesis in Ginkgo
biloba. I. Studies of synthesis, translocation and accumulation of ginkgolides and bilobalide. Plant Physiol
Biochem 35:859–868, 1997. - R Upton. St. John’s Wort. Quality Control, Analytical and Therapeutic Monograph. Santa Cruz, CA: American
Herbal Pharmacopoeia Comendium, 1998. - HD Reuter. Chemistry and biology of Hypericum perforatum(St. John’s wort). In: LD Lawson, R Bauer, eds.
Phytomedicines of Europe. Chemistry and Biological Activity. Washington, DC: American Chemical Society,
1998, pp 287–298. - RB Fornasiero, A Bianchi, A Pinetti. Anatomical and ultrastructural observations in Hypericum perforatumL.
leaves. J Herb Spice Med Plant 5:21–33, 1998. - A Nahrstedt, V Butterwick. Biologically active and other chemical constituents of the herb of Hypericum per-
foratumL. Pharmacopsychiatry 30:129–134, 1997. - G Laakman, C Schule, T Baghai, M Kieser. St. John’s wort in mild to moderate depression—the relevance of
hyperforin for the clinical efficacy. Pharmacopsychiatry 31:54–59, 1998. - SS Chatterjee, SK Bhattacharya, M Wonneman, A Singer, WE Muller. Hyperforin as a possible antidepressant
component of Hypericumextracts. Life Sci 63:499–510, 1998. - O Sticher. Biochemical, pharmaceutical and medical perspectives of ginseng. In: LD Lawson, R Bauer, eds.
Phytomedicines of Europe. Chemistry and Biological Activity. Washington, DC: American Chemical Society,
1998, pp 221–240.
498 BRISKIN